# DB Engineering & Consulting (Germany)

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/db-engineering-and-consulting-germany/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 78.7 |
| Citations | 6,868 |
| City | Berlin |
| Country | DE |
| Description | DB Engineering & Consulting (Germany) is a research organisation in Berlin, DE. OpenAlex records 951 works and 6,868 citations for it. 254 researchers list it as their most recent affiliation. |
| Homepage | https://www.db-engineering-consulting.de/db-ec-de |
| OpenAlex ID | https://openalex.org/I4210089142 |
| Researchers | 254 |
| ROR ID | https://ror.org/005ma5a25 |
| Type | company |
| Works | 951 |

## University papers

Showing 12 of 24.

- [Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003](https://scholariq.org/papers/revised-nomenclature-for-allergy-for-global-use-report-of-the-nomenclature/)
- [Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis](https://scholariq.org/papers/two-phase-3-trials-of-dupilumab-versus-placebo-in-atopic-dermatitis/)
- [Atopic Dermatitis](https://scholariq.org/papers/atopic-dermatitis-4/)
- [Atopic dermatitis](https://scholariq.org/papers/atopic-dermatitis-2/)
- [Dupilumab Treatment in Adults with Moderate-to-Severe Atopic Dermatitis](https://scholariq.org/papers/dupilumab-treatment-in-adults-with-moderate-to-severe-atopic-dermatitis/)
- [Consensus‐based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part I](https://scholariq.org/papers/consensus-based-european-guidelines-for-treatment-of-atopic-eczema-atopic/)
- [Atopic dermatitis](https://scholariq.org/papers/atopic-dermatitis-5/)
- [Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report](https://scholariq.org/papers/diagnosis-and-treatment-of-atopic-dermatitis-in-children-and-adults-european/)
- [Consensus‐based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part II](https://scholariq.org/papers/consensus-based-european-guidelines-for-treatment-of-atopic-eczema-atopic-2/)
- [Guidelines for treatment of atopic eczema (atopic dermatitis) Part I](https://scholariq.org/papers/guidelines-for-treatment-of-atopic-eczema-atopic-dermatitis-part-i/)
- [Cellular and molecular immunologic mechanisms in patients with atopic dermatitis](https://scholariq.org/papers/cellular-and-molecular-immunologic-mechanisms-in-patients-with-atopic-dermatitis/)
- [Efficacy and safety of dupilumab in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical treatments: a randomised, placebo-controlled, dose-ranging phase 2b trial](https://scholariq.org/papers/efficacy-and-safety-of-dupilumab-in-adults-with-moderate-to-severe-atopic/)

## University researchers

- [Thomas Bieber](https://scholariq.org/researchers/thomas-bieber/)

## University top topics

Showing 8 of 13.

- [Global trade and economics](https://scholariq.org/topics/global-trade-and-economics/)
- [Digital Innovation in Industries](https://scholariq.org/topics/digital-innovation-in-industries/)
- [Flexible and Reconfigurable Manufacturing Systems](https://scholariq.org/topics/flexible-and-reconfigurable-manufacturing-systems/)
- [Fiscal Policy and Economic Growth](https://scholariq.org/topics/fiscal-policy-and-economic-growth/)
- [Business Process Modeling and Analysis](https://scholariq.org/topics/business-process-modeling-and-analysis/)
- [Global Trade and Competitiveness](https://scholariq.org/topics/global-trade-and-competitiveness/)
- [Economic Growth and Productivity](https://scholariq.org/topics/economic-growth-and-productivity/)
- [Banking stability, regulation, efficiency](https://scholariq.org/topics/banking-stability-regulation-efficiency/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.